BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced that Fresenius Kabi USA (Lake Zurich, IL) acquired the BD Rx (Franklin Lakes, NJ) business, which includes a pharmaceutical manufacturing plant in Wilson, NC, and the BD Simplist line of seven drugs in ready-to-administer prefilled glass syringes. BD and Fresenius Kabi also signed a 10-year supply and distribution agreement under which Fresenius Kabi will supply BD with a portfolio of intravenous solutions. Both companies plan to offer a range of IV solutions in the U.S. beginning in 2016. Additional financial and contractual terms of the transactions were not disclosed.
Market Pulse transactions shown herein are provided as a matter of public record. These transactions have been compiled from press releases, corporate announcements and other public sources to provide an overview of acquisition and merger activities within the healthcare and life sciences sectors.